GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea
· Delayed Price · Currency is KRW 4,780.00
-35.00 (-0.73%)
At close: Apr 28, 2026
GeneBioTech Co. ,Ltd Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 40,168 | 34,528 | 28,329 | 37,542 | 34,356 | 45,119 | Upgrade
|
| Market Cap Growth | 53.20% | 21.88% | -24.54% | 9.27% | -23.86% | -8.87% | Upgrade
|
| Enterprise Value | 30,229 | 26,516 | 19,776 | 30,940 | 31,105 | 35,590 | Upgrade
|
| Last Close Price | 4665.00 | 4010.00 | 3249.43 | 4306.24 | 3940.80 | 5175.39 | Upgrade
|
| PE Ratio | 10.60 | 9.11 | 9.89 | 14.49 | 22.55 | - | Upgrade
|
| PS Ratio | 0.44 | 0.38 | 0.34 | 0.47 | 0.42 | 0.72 | Upgrade
|
| PB Ratio | 0.73 | 0.63 | 0.56 | 0.78 | 0.75 | 1.03 | Upgrade
|
| P/TBV Ratio | 0.74 | 0.64 | 0.56 | 0.79 | 0.77 | 1.05 | Upgrade
|
| P/FCF Ratio | 10.42 | 8.95 | - | 5.49 | - | - | Upgrade
|
| P/OCF Ratio | 5.28 | 4.54 | - | 5.10 | - | - | Upgrade
|
| EV/Sales Ratio | 0.33 | 0.29 | 0.24 | 0.39 | 0.38 | 0.57 | Upgrade
|
| EV/EBITDA Ratio | 5.62 | 4.93 | 3.79 | 5.83 | 10.94 | 44.98 | Upgrade
|
| EV/EBIT Ratio | 7.57 | 6.64 | 5.15 | 7.79 | 19.98 | - | Upgrade
|
| EV/FCF Ratio | 7.84 | 6.88 | - | 4.52 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.27 | 0.31 | 0.26 | 0.28 | 0.23 | Upgrade
|
| Debt / EBITDA Ratio | 2.78 | 2.78 | 3.05 | 2.35 | 4.58 | 13.02 | Upgrade
|
| Debt / FCF Ratio | 3.88 | 3.88 | - | 1.83 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.18 | -0.18 | -0.15 | -0.20 | -0.07 | -0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.85 | -1.85 | -1.44 | -1.79 | -1.08 | -9.46 | Upgrade
|
| Net Debt / FCF Ratio | -2.58 | -2.58 | 4.81 | -1.39 | 0.63 | 1.29 | Upgrade
|
| Asset Turnover | 1.23 | 1.23 | 1.20 | 1.22 | 1.33 | 1.03 | Upgrade
|
| Inventory Turnover | 4.92 | 4.92 | 4.37 | 4.35 | 4.97 | 4.59 | Upgrade
|
| Quick Ratio | 2.39 | 2.39 | 2.02 | 2.33 | 1.91 | 1.99 | Upgrade
|
| Current Ratio | 3.48 | 3.48 | 3.04 | 3.40 | 2.91 | 2.98 | Upgrade
|
| Return on Equity (ROE) | 7.15% | 7.15% | 5.77% | 5.51% | 3.40% | -1.03% | Upgrade
|
| Return on Assets (ROA) | 3.38% | 3.38% | 3.48% | 3.82% | 1.56% | -0.46% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.53% | 7.75% | 7.65% | 7.49% | 3.30% | -1.39% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.70% | 6.70% | 7.20% | 7.70% | 3.20% | -1.00% | Upgrade
|
| Earnings Yield | 9.43% | 10.97% | 10.11% | 6.90% | 4.43% | -1.07% | Upgrade
|
| FCF Yield | 9.60% | 11.17% | -5.52% | 18.21% | -14.07% | -12.89% | Upgrade
|
| Buyback Yield / Dilution | -0.08% | -0.08% | 0.07% | - | - | - | Upgrade
|
| Total Shareholder Return | 0.96% | -0.08% | 0.07% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.